BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//VHL Alliance - ECPv6.13.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://vhl.org
X-WR-CALDESC:Events for VHL Alliance
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20241114T183000
DTEND;TZID=America/New_York:20241114T193000
DTSTAMP:20260424T030808
CREATED:20241008T141354Z
LAST-MODIFIED:20241008T150006Z
UID:10000103-1731609000-1731612600@vhl.org
SUMMARY:Advances in VHL Disease and HIF2a Inhibitors: Insights from Recent Research with Othon Iliopoulos\, MD\, PhD
DESCRIPTION:  \nDate & Time: Nov 14th\, 6:30 pm EST \n  \nLocation: Zoom (Link to be provided upon registration) \n  \nJoin us for an informative webinar featuring renowned VHL researcher Dr. Othon Iliopoulos as he delves into the latest advancements in understanding Von Hippel-Lindau (VHL) disease and the role of HIF2a inhibitors in treatment. \n  \nDr. Iliopoulos will present key insights from his recently published article\, “Updated Findings with Belzutifan in Von Hippel-Lindau Disease-Associated CNS Hemangioblastomas\,” highlighting the significant impacts of belzutifan on patient outcomes. He will discuss the mechanisms of VHL disease\, the role of HIF2a in tumorigenesis\, and the therapeutic potential of HIF2a inhibitors. \n  \nKey Topics: \n\nOverview of VHL disease and its implications\nMechanism of action of HIF2a inhibitors\nRecent clinical findings and their relevance for patient care\nFuture directions in VHL disease research and treatment strategies\n\n  \nThis webinar is an excellent opportunity for healthcare professionals\, researchers\, and anyone interested in the latest developments in VHL disease to engage with Dr. Iliopoulos and gain valuable insights into ongoing research and clinical applications. \n  \nRegister now to secure your spot and be part of this engaging discussion!
URL:https://vhl.org/vhla-event/advances-in-vhl-disease-and-hif2a-inhibitors-insights-from-recent-research-with-othon-iliopoulos-md-phd/
LOCATION:Zoom / Online
CATEGORIES:Workshop
ATTACH;FMTTYPE=image/jpeg:https://vhl.org/wp-content/uploads/2024/10/VHL-101-Research-Update-with-Othon-Iliopoulos-MD.jpg
END:VEVENT
END:VCALENDAR